Biological Information

Background Information:

The PathHunter® BTLA Signaling Cell Line (Jurkat) is a stable, engineered cell line for use in studying molecules and drug candidates targeting signaling checkpoints. This cell line enables assessment of BTLA induced non-canonical NF-κB signaling via detection of SH2 domain protein recruitment. This product uses EFC technology. The included cell line overexpresses PK-tagged BTLA target protein and EA-tagged SH2 domain protein. Upon activation of the receptor by its ligand or an agonist antibody, recruitment of SH2 domain protein to the phosphorylated receptor tail leads to production of EFC signal.
This stable engineered cell line is provided as two vials of cryopreserved cells.

Target Class:

Checkpoint Receptor

Protein Name:

BTLA

Accession Number:

NM_181780.3

UniProt Number:

Q7Z6A9

Gene Name:

BTLA

Gene ID:

151888

Gene Aliases:

BTLA1|CD272

Target Species:

Human

Cell Background:

Jurkat

Usage

Product Type:

Stable Cell Lines

Application:

Drug Discovery & Development

Storage Conditions:

Store in vapor phase of liquid nitrogen.

Usage disclaimer:

These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Assay Information

Assay Type:

Cell Based

Assay Measures:

Signaling

Detection Method:

Chemiluminescence

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology

Additional Information

Brand:

PathHunter®